NCT05161299|UnknownDMC
CovidSurg-3: Outcomes of Surgery in COVID-19 Infection
CovidSurg-3
Loading search results
CovidSurg-3
Sponsor study identifier
observational
2,000
1 country
1
Study Start
December 13, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 28, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 29, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
COVID-19 has significant detrimental impacts on surgical systems and patient outcomes. CovidSurg has provided the best available evidence to guide delivery of safe surgery during the pandemic. However, CovidSurg data were collected in 2020 when the wildtype SARS-CoV-2 virus was dominant, and therefore there is a need to for renewed rapid data to guide global practice during Omicron COVID-19 waves. CovidSurg-3 is an extension to CovidSurg and was initiated in response to the emergence of the Omicron variant. CovidSurg-3 has two separate components:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 29, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 13, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 16, 2021
Actual (reported)December 17, 2021
Actual (reported)February 28, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 29, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
To determine 30-day mortality in patients with peri-operative SARS-CoV-2 infection
Collection of outcome data (up to 30 days post-surgery) for patients with peri-operative SARS-CoV-2
Up to 30 days post-surgery
Rates of post-operative pulmonary complication and venous thromboembolism
Up to 30 days post-surgery
Evaluate implementation of SARS-CoV-2 mitigations and adaptations (vaccination, preoperative testing, COVID-free surgical pathways, patient selection)
Recruitment period (mid Dec 2021 - end Feb 2022)
Frequency of peri-operative SARS-CoV-2 infection
56 days
Frequency of same-day elective surgery cancellations
56 days
Patients that underwent surgery (across all specialities), performed by a surgeon in an operating theatre, AND had a positive SARS-CoV-2 PCR swab or rapid antigen test (if PCR swab is not available) within 7 days before or 30 days after surgery. Patients can be included regardless of whether a specific variant is suspected or unknown
Surgery performed by a surgeon in an operating theatre during the patient inclusion period
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
All patients that underwent a surgical procedure during the patient inclusion period - 13 December 2021 to 28 February 2022 inclusive, regardless of surgical indication (benign surgery, cancer surgery, trauma, obstetric), anaesthetic type (local, regional, general), surgical approach (minimally invasive surgery, open surgery), or whether it is day-case or in-patient surgery
University of Birmingham
Birmingham, United Kingdom
Aneel Bhangu
University of Birmingham
First Submitted
December 16, 2021
First Posted
December 17, 2021
Study Start
December 13, 2021
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
February 28, 2022
Estimated (date passed)Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 29, 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
December 17, 2021
Record last verified: 2021-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: